Adempas — United Healthcare
chronic thromboembolic pulmonary hypertension (CTEPH)
Initial criteria
- Diagnosis of inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) which is symptomatic
Reauthorization criteria
- Documentation of positive clinical response to Adempas therapy
Approval duration
12 months